{
  "pmcid": "8038254",
  "sha256": "f3765a08b52b282479a2863ed64baf8a8d13f4a7ae3d7a69ce6444be3e5e5f46",
  "timestamp_utc": "2025-11-09T16:16:09.598330+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.61120961060481,
    "reading_ease": 27.23205053852527,
    "word_count": 284
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "Of 525 patients with HCC who had liver transplantation, 350 recipients underwent pretransplant bridging therapy."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "Here, the relationship between pretransplant bridging therapy and long-term survival was investigated in a subgroup analysis of the SiLVER Study."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Tumour progression despite bridging was an independent risk factor affecting overall survival (hazard ratio 1.80; P =â€‰0.005)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 4,
    "max_score": 25
  }
}